The total return over the past 12 months is -55.49% vs. +19.51% for the S&P 500. So far it's up -50.99% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (55.49%) | (3.41%) | +0.49% | +6.76% | +13.32% | +5.18% |
| Total Return CAGR | (55.49%) | (3.41%) | +0.49% | +6.76% | +13.32% | +5.18% |
| Revenue CAGR | +13.53% | +16.15% | +13.40% | +10.19% | +6.81% | +5.81% |
| Net Income CAGR | +46.68% | +59.04% | +47.60% | +28.58% | +12.93% | +9.34% |
| EPS CAGR | +55.60% | +63.44% | N/A | +14.62% | +4.85% | +4.85% |
| Free Cash Flow CAGR | +19.81% | +43.03% | +19.89% | +18.10% | +19.59% | +7.87% |
| Operating Cash Flow CAGR | +13.88% | +34.75% | +18.36% | +16.87% | +15.31% | +7.48% |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Boston Scientific Corporation (BSX)
| Year | Start Value | End Value | BSX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | 854.68 | 418.87 | (50.99%) | +10.13% | (61.12%) |
| 2025 | 800.63 | 854.68 | +6.75% | +17.72% | (10.97%) |
| 2024 | 518.18 | 800.63 | +54.51% | +24.89% | +29.62% |
| 2023 | 414.75 | 518.18 | +24.94% | +26.19% | (1.25%) |
| 2022 | 380.77 | 414.75 | +8.92% | (18.17%) | +27.09% |
| 2021 | 322.24 | 380.77 | +18.16% | +28.74% | (10.58%) |
| 2020 | 405.33 | 322.24 | (20.50%) | +18.37% | (38.87%) |
| 2019 | 316.77 | 405.33 | +27.96% | +31.22% | (3.26%) |
| 2018 | 222.21 | 316.77 | +42.56% | (4.56%) | +47.12% |
| 2017 | 193.88 | 222.21 | +14.61% | +21.70% | (7.09%) |
